• Maia Leite A, Ronga MG, Giorgi M, Ristic Y, Perrot Y, Trompier F, Prezado Y, Créhange G, De Marzi L. Secondary neutron dose contribution from pencil beam scanning, scattered and spatially fractionated proton therapy. Phys Med Biol, in press, 2021. DOI: https://doi.org/10.1088/1361-6560/ac3209 

  • Hahn C, Ödén J, Dasu A, Vestergaard A, Fuglsang Jensen M, Sokol O, Pardi C, Bourhaleb F, Leite A, de Marzi L, Smith E, Aitkenhead A, Rose C, Merchant M, Kirkby K, Grzanka L, Pawelke J, Lühr A. Towards harmonizing clinical linear energy transfer (LET) reporting in proton radiotherapy: a European multi-centric study. Acta oncologica, 1–9, 2021. DOI:  https://doi.org/10.1080/0284186X.2021.1992007

  • Créhange G, Goudjil F, Krhili SL, Minsat M, de Marzi L, Dendale R. The role of proton therapy in esophageal cancer. Cancer radiotherapie, S1278-3218(21)00248-1, 2021. DOI: https://doi.org/10.1016/j.canrad.2021.08.015

  • Ronga MG, Cavallone M, Patriarca A, Leite AM, Loap P, Favaudon V, Créhange G, De Marzi L. Back to the Future: Very High-Energy Electrons (VHEEs) and Their Potential Application in Radiation Therapy. Cancers. 13:4942, 2021. DOI: https://doi.org/10.3390/cancers13194942

  • Bertho A, Ortiz R, Juchaux M, Gilbert C, Lamirault C, Pouzoulet F, Polledo L, Liens A, Warfving N, Sebrie C, Jourdain L, Patriarca A, de Marzi L, Prezado Y. First Evaluation of Temporal and Spatial Fractionation in Proton Minibeam Radiation Therapy of Glioma-Bearing Rats.  Cancers. 13(19):4865, 2021. DOI: https://doi.org/10.3390/cancers13194865

  • Loap P, Vitolo V, Barcellini A, De Marzi L, Mirandola A, Fiore MR, Vischioni B, Jereczek-Fossa BA, Girard N, Kirova YM, Orlandi E. Hadrontherapy for thymic epithelial tumors: implementation in clinical practice. Front. Oncol. 11:738320, 2021. DOI: https://doi.org/10.3389/fonc.2021.738320

  • Bradshaw TJ, Boellaard R, Dutta J, Jha AK, Jacobs P, Li Q, Liu C, Sitek A, Saboury B, Scott PJH, Slomka PJ, Sunderland JJ, Wahl RL, Yousefirizi F, Zuehlsdorff S, Rahmim A, Buvat I. Nuclear Medicine and Artificial Intelligence: Best Practices for Algorithm Development. J Nucl Med. in press, 2021.

  • Wimberley C, Buvat I, Boutin H. Imaging translocator protein expression with Positron Emission Tomography. Eur J Nucl Med Mol Imaging. in press, 2021.

  • Kolinger GD, García DV, Kramer GM, Frings V, Zwezerijnen GJC, Smit EF, De Langen AJ, Buvat I, Boellaard R. Effects of tracer uptake time in non-small cell lung cancer 18F-FDG PET radiomics. J Nucl Med. in press, 2021.
  • Sabra D, Intzandt B, Desjardins-Crépeau L, Langeard A, Steele CJ, Frouin F, Hoge RD, Bherer L, Gauthier C. Sex moderates the relationship between aortic stiffness, cognition, and cerebrovascular reactivity in healthy older adults.  Plos One, in press, 2021.

  • Peters N, Wohlfahrt P, Dahlgren CV, de Marzi L, Ellerbrock M, Fracchiolla F, Freeh J, Gomà C, Góra J, Jensen MF, Kajdrowicz T, Mackay R, Molinelli S, Rinaldi I, Rompokos V, Siewert D, van der Tol P, Vermeren X, Nyström H, Lomax A, Richter C. Experimental assessment of inter-centre variation in stopping-power and range prediction in particle therapy. Radiother Oncol. 163:7-13, 2021. DOI: https://doi.org/10.1016/j.radonc.2021.07.019

  • Loap P, Mirandola A, De Marzi L, Dendale R, Iannalfi A, Vitolo V, Barcellini A, Filippi AR, Jereczek-Fossa BA, Kirova Y, Orlandi E. Current Situation of Proton Therapy for Hodgkin Lymphoma: from Expectations to Evidence. Cancers 13: 3746, 2021. DOI: https://doi.org/10.3390/cancers13153746 

  • Loap P, De Marzi L, Mirandola A, Dendale R, Iannalfi A, Vitolo V, Barcellini A, Filippi AR, Jereczek-Fossa BA, Kirova Y, Orlandi E. Development and Implementation of Proton Therapy for Hodgkin Lymphoma: Challenges and Perspectives. Cancers, 13:3744, 2021. DOI: https://doi.org/10.3390/cancers13153744

  • Vidal M, Moignier C, Patriarca A, Sotiropoulos M, Schneider T, De Marzi L. Future technological developments in proton therapy - a predicted technological breakthrough. Cancer Radiother. In press, 2021. DOI: https://doi.org/10.1016/j.canrad.2021.06.017
  • Malaise D, Houillier C, Touitou V, Choquet S, Maloum K, Le Garff-Tavernier M, Davi F, Vincent-Salomon A, Feuvret L, Hoang-Xuan K, Cassoux N, Soussain C. LOC network and the ERN-EuroBloodNet. Primary vitreoretinal lymphoma: short review of the literature, results of a European survey and French guidelines of the LOC network for diagnosis, treatment and follow-up. Curr Opin Oncol. 33:420-431, 2021. DOI: 10.1097/CCO.0000000000000776.

  • Soussain C, Malaise D, Cassoux N. Primary vitreoretinal lymphoma: A diagnostic and management challenge. Blood. 2021 May 25:blood.2020008235. DOI: 10.1182/blood.2020008235.  

  • Orlhac F, Eertink JJ, Cottereau AS, Zijlstra JM, Thieblemont C, Meignan M, Boellaard R, Buvat I. A guide to ComBat harmonization of imaging biomarkers in multi center studies. J Nucl Med. in press, 2021. DOI: https://doi.org/10.2967/jnumed.121.262464 
  • Jehan-Besson S, Clouard R, Boddaert N, Grill J, Frouin F. Optimization of a Shape Metric Based on Information Theory Applied to Segmentation Fusion and Evaluation in Multimodal MRI for DIPG Tumor Analysis. Proceedings of 5th International Conference GSI 2021: 772-780.

  • Cottereau AS, Meignan M, Nioche C, Clerc J, Chartier L, Vercellino L, Casasnovas O, Thieblemont C, Buvat I. New approaches in characterisation of lesions dissemination in DLBCL patients on baseline PET/CT. Cancers. 13:3998, 2021. DOI: https://doi.org/10.3390/cancers13163998 

  • Seban RD, Donnadieu A, Journo G, Bidard FC, Richard C, Rouzier R, Champion L.18F-FDG PET/CT in Relapsed Endometrial Cancer Treated with Preoperative PD-1 Inhibitor Dostarlimab. Diagnostics. 11:1353, 2021. DOI: https://doi.org/10.3390/diagnostics11081353
  • Seban RD, Synn S, Muneer I, Champion L, Schwartz LH, Dercle L. Don't overlook spleen glucose metabolism on [18F]-FDG PET/CT for cancer drug discovery and development. Curr Cancer Drug Targets. DOI: 10.2174/1568009621666210720143826. in press, 2021.

  • Seban RD, Assié JB, Giroux-Leprieur E, Massiani MA, Bonardel G, Chouaid C, Deleval N, Richard C, Mezquita L, Girard N, Champion L. Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy. Lung Cancer. 159: 45-55, 2021. DOI: https://doi.org/10.1016/j.lungcan.2021.06.024 
  • Wallis D, Soussan M, Lacroix M, Akl P, Duboucher C, Buvat I. An FDG-PET/CT deep learning method for fully automated detection of pathological mediastinal lymph nodes in lung cancer patients. Eur J Nucl Med Mol Imaging. in press, 2021. DOI: https://doi.org/10.1007/s00259-021-05513-x

  • Orlhac F, Nioche C, Klyuzhin I, Rahmim A, Buvat I. Radiomics in PET imaging - A practical guide for newcomers. PET Clin. in press, 2021. 

  • Seban RD, Champion L, Yeh R, Schwartz LH, Dercle L. Assessing immune response upon systemic RNA vaccination on [18F]-FDG PET/CT for COVID-19 vaccine and then for immune-oncology? (letter to the Editor). Eur J Nucl Med Mol Imaging. in press, 2021. DOI: 10.1007/s00259-021-05468-z

  • Seban RD, Champion L, Muneer I, Synn S, Schwartz LH, Dercle L. Potential theranostic role of bone marrow glucose metabolism on baseline [18F]-FDG PET/CT in metastatic melanoma (letter to the Editor). J Nucl Med. In press, 2021. DOI: 10.2967/jnumed.121.262361
  • Dumas JL, Dal R, Zefkili S, Robilliard M, Losa S, Birba I, Vu-Bezin J, Beddok A, Calugaru V, Dutertre G, De Marzi L. Addressing the dosimetric impact of bone cement and vertebroplasty in stereotactic body radiation therapy. Phys Med. 202185:42-49. DOI: 10.1016/j.ejmp.2021.04.023.

  • Costa E, Richir T, Robilliard M, Bragard C, Logerot C, Kirova Y, Fourquet A, De Marzi L. Assessment of a conventional volumetric-modulated arc therapy knowledge-based planning model applied to the new Halcyon© O-ring linac in locoregional breast cancer radiotherapy. Phys Med. 86:32-43. 2021. DOI: 10.1016/j.ejmp.2021.05.022.  
  • Orlhac F, Buvat I. Comment on Ibrahim, A. et al. The Effects of In-Plane Spatial Resolution on CT-Based Radiomic Features’ Stability with and without ComBat Harmonization. Cancers. In press, 2021. DOI: https://doi.org/10.3390/cancers13123037 

  • Seban RD, Vermersch C, Champion L, Bonsang B, Roger A, Ghidaglia J. Immune-Related Erythema Nodosum Mimicking in Transit Melanoma Metastasis on [18F]-FDG PET/CT. Diagnostics. 11: 747, 2021. DOI: https://doi.org/10.3390/diagnostics11050747

  • Aide N, Lasnon C, Kesner A, Levin C, Buvat I, Iagaru A, Hermann K, Badawi RD, Cherry SR, Bradley KM, McGowan DR. New PET technologies: embracing progress and pushing the limits. Eur J Nucl Med Mol Imaging. 48: 2711–2726, 2021. DOI: https://doi.org/10.1007/s00259-021-05390-4

  • Beyer T, Bailey DL, Birk UJ, Buvat I, Catana C, Cheng Z, Fang Q, Giove F, Kuntner C, Laistler E, Moscato F, Nekolla SG, Rausch I, Ronen I, van Elmpt W, Saarakkala S, Thielemans K, Moser E. Medical Physics and Imaging – A timely perspective. Frontiers in Physics. 2021. sous presse. DOI: https://doi.org/10.3389/fphy.2021.634693

  • Seban RD, Champion L, Deleval N, Richard C, Provost C. Immune Response Visualized In Vivo by [18F]-FDG PET/CT after COVID-19 Vaccine. Diagnostics. 11: 676, 2021. DOI: https://doi.org/10.3390/diagnostics11040676
  • Seban RD, Rouzier R, Latouche A, Deleval N, Guinebretiere JM, Buvat I, Bidard FC, Champion L. Total metabolic tumor volume and spleen metabolism on baseline [18F]-FDG PET/CT as independent prognostic biomarkers of recurrence in resected breast cancer. Eur J Nucl Med Mol Imaging. in press, 2021. DOI: https://doi.org/10.1007/s00259-021-05322-2 

  • Schneider T, De Marzi L, Patriarca A and Prezado Y. Monte Carlo Comparison of Proton and Helium-ion Minibeam Generation Techniques. Front. Phys. 9:595721, 2021. DOI: https://doi.org/10.3389/fphy.2021.595721
  • Loto O, Zahradnik I, Leite AM, De Marzi L, Tromson D, Pomorski M. Simultaneous measurements of dose and microdosimetric spectra in a clinical proton beam using a scCVD diamond membrane microdosimeter. Sensors (Basel). 21:1314, 2021. DOI: https://www.mdpi.com/1424-8220/21/4/1314

  • Leduc A, Chaouni S, Pouzoulet F, De Marzi L, Megnin-Chanet F, E Corre, Stefan D, Habrand JL, Sichel F, Laurent C. Differential normal skin transcriptomic response in total body irradiated mice exposed to scattered versus scanned proton beams. Sci Rep 11, 5876, 2021. DOI: https://doi.org/10.1038/s41598-021-85394-0
  • Buvat I, Orlhac FThe T.R.U.E. checklist for identifying impactful AI-based findings in nuclear medicine: is it True? Is it Reproducible? Is it Useful? Is it Explainable? J Nucl Med. 62: 752-754, 2021. DOI: https://doi.org/10.2967/jnumed.120.261586 

  • Prezado Y, Hirayama R, Matsufuji N, Inaniwa T, Martínez-Rovira I, Seksek O, Bertho A, Koike S, Labiod D, Pouzoulet F, Polledo L, Warfving N, Liens A, Bergs J, Shimokawa T. A potential renewed use of very heavy ions for therapy: Neon minibeam radiation therapy. Cancers. 13:1356, 2021. DOI: 10.3390/cancers13061356
  • Weber M, Kersting D, Umutlu L, Schäfers M, Rischpler C, Fendler WP, Buvat I, Herrmann K, Seifert R. Just another ‘Clever Hans’? Neural Networks and FDG PET‑CT to predict the Outcome of Patients with Breast Cancer. Eur J Nucl Med Mol Imaging. in press, 2021.

  • Seban RD, Champion L, Schwartz LH, Dercle L. Spleen glucose metabolism on [F-18]-FDG PET/CT: a dynamic double-edged biomarker predicting outcome in cancer patients (letter to the Editor). Eur J Nucl Med Mol Imaging. in press, 2021. DOI: 10.1007/s00259-020-05126-w